Bulletin
Investor Alert

Edesa Biotech Inc.

NAS: EDSA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 23, 2022, 7:28 p.m.

/zigman2/quotes/200172674/composite

$

2.05

Change

+0.18 +9.63%

Volume

Volume 10

Quotes are delayed by 20 min

/zigman2/quotes/200172674/composite

Today's close

$ 1.82

$ 1.87

Change

+0.05 +2.75%

Day low

Day high

$1.81

$1.89

Open

52 week low

52 week high

$1.72

$12.00

Open

Insider Actions for Edesa Biotech Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/31/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $2.99 per share. 5,980
03/30/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,100
03/30/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,100
03/30/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $3.05 per share. 6,100
03/29/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,040
03/29/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,040
03/29/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $3.02 per share. 6,040
03/18/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   7,700
03/18/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   7,700
03/18/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $3.85 per share. 7,700
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,603   5,225
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
397   1,290
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,603   5,225
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
397   1,290
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,603   Acquisition at $3.26 per share. 5,225
03/17/2022 Pardeep Nijhawan
Chief Executive Officer; Director
397   Acquisition at $3.25 per share. 1,290
03/15/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   5,600
03/15/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   5,600
03/15/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $2.8 per share. 5,600
03/14/2022 Michael Brooks
1,250   3,487
03/14/2022 Michael Brooks
1,250   3,487
03/14/2022 Michael Brooks
1,250   Acquisition at $2.79 per share. 3,487
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
5,000   15,300
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,360
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
5,000   15,300
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   6,360
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
5,000   Acquisition at $3.06 per share. 15,300
03/11/2022 Pardeep Nijhawan
Chief Executive Officer; Director
2,000   Acquisition at $3.18 per share. 6,360
03/10/2022 Michael Brooks
1,000   3,220
03/10/2022 Michael Brooks
1,000   3,220
03/10/2022 Michael Brooks
1,000   Acquisition at $3.22 per share. 3,220
03/09/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,500   4,575
03/09/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,500   4,575
03/09/2022 Pardeep Nijhawan
Chief Executive Officer; Director
1,500   Acquisition at $3.05 per share. 4,575

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
37 Purchases
0 Sales
68,000
0
Last 6 months
37 Purchases
0 Sales
68,000
0
Last 12 months
37 Purchases
0 Sales
68,000
0

Officers and Executives

Dr. Pardeep Nijhawan
Chief Executive Officer, Secretary & Director
Dr. Michael Brooks
President
Ms. Kathi Niffenegger
Chief Financial Officer
Dr. Blair Gordon
Vice President-Research & Development
Mr. Rajan Puri
Senior Vice President-Manufacturing
Mr. Frank R. Oakes
Director
Ms. Jennifer M. Chao
Director
Mr. Gary Koppenjan
Vice President-Investor Relations & Communications
Mr. Sean A. MacDonald
Chairman
Dr. Lorin K. Johnson
Independent Director
Mr. Paul William Pay
Independent Director
Mr. Carlo Sistilli
Independent Director
Link to MarketWatch's Slice.